Rando Emanuele, Oliva Alessandra, Cancelli Francesca, D'Agostino Claudia, Savelloni Giulia, Ciardi Maria Rosa, Ajassa Camilla, Siccardi Guido, Galardo Gioacchino, Mastroianni Claudio M
Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.
Infez Med. 2023 Mar 1;31(1):49-54. doi: 10.53854/liim-3101-7. eCollection 2022.
Since the beginning of 2020, the SARS-CoV-2 pandemic has become a serious public health problem. Numerous studies have highlighted the main clinical features of COVID-19, mainly the huge heterogeneity of the clinical manifestations that can vary from asymptomatic infection to serious viral pneumonia with a high mortality rate. The aim of this study was to analyze retrospectively the clinical characteristics and assess the risk factors for mortality in an Italian cohort of patients with COVID-19.
Retrospective analysis including patients with COVID-19 admitted to the Infectious Diseases wards of Azienda Ospedaliera Universitaria Policlinico "Umberto 1", Rome, from March 2020 to May 2020. The data were part of an electronic anonymous web-based database processed by SIMIT (Italian Society of Infectious and Tropical Diseases).
258 patients were included in the analysis, and 34 (13.2%) died. The median age was 62 (IQR, 52-74), 106 (40%) were women, and 152 (60%) were males, 172 (66.7%) had at least one co-morbidity. The most common signs and symptoms were: fever [221 (85.6%)], cough [135 (52.3%)], and dyspnea [133 (51.5%)]. The PaO2/FiO2 ratio was often altered [352 (IQR, 308-424)]. Lymphopenia [lymphocyte counts, 875/μL (IQR, 640-1250)] and high levels of D-dimer [mg/dL, 874 (IQR, 484-1518)] were found. Non-survivors were older than survivors [median age, 74 (IQR, 67-85)] vs. 61 (QR, 51-72)], mostly men [25 (73.5%)] and more frequently with more than 2 comorbidities [21 (61.8%) vs. 94 (42.1%)]. In the multiple logistic regression model, the variables associated with in-hospital mortality were age [OR, 3.65 (95% CI, 1.22-10.89)], male gender [OR, 2.99 (95% CI, 1.18-7.54)], blood urea [OR, 2.76 (95% CI, 1.20-6.35)] and a low PaO2/FiO2 ratio [OR, 0.28 (95% CI, 0.12-0.62)].
The mortality rate in COVID-19 was 13,2%. The risk factors associated with in-hospital mortality were advanced age, male sex, increased blood urea, and the PaO2/FiO2 ratio reduction.
自2020年初以来,严重急性呼吸综合征冠状病毒2(SARS-CoV-2)大流行已成为一个严重的公共卫生问题。众多研究突出了新型冠状病毒肺炎(COVID-19)的主要临床特征,主要是临床表现的巨大异质性,其可从无症状感染到具有高死亡率的严重病毒性肺炎不等。本研究的目的是回顾性分析意大利一组COVID-19患者的临床特征并评估死亡风险因素。
回顾性分析纳入了2020年3月至2020年5月期间入住罗马“翁贝托一世”大学综合医院传染病病房的COVID-19患者。这些数据是由意大利传染病和热带病学会(SIMIT)处理的基于网络的电子匿名数据库的一部分。
258例患者纳入分析,34例(13.2%)死亡。中位年龄为62岁(四分位间距,52 - 74岁),106例(40%)为女性,152例(60%)为男性,172例(66.7%)至少有一种合并症。最常见的体征和症状为:发热[221例(85.6%)]、咳嗽[135例(52.3%)]和呼吸困难[133例(51.5%)]。动脉血氧分压/吸入氧分数值(PaO2/FiO2)比值常发生改变[352例(四分位间距,308 - 424)]。发现淋巴细胞减少[淋巴细胞计数,875/μL(四分位间距,640 - 1250)]和D - 二聚体水平升高[mg/dL,874(四分位间距,484 - 1518)]。非幸存者比幸存者年龄更大[中位年龄,74岁(四分位间距,67 - 85岁)对61岁(四分位间距,51 - 72岁)],大多为男性[25例(73.5%)],且更频繁地患有超过2种合并症[21例(61.8%)对94例(42.1%)]。在多因素逻辑回归模型中,与院内死亡相关的变量为年龄[比值比(OR),3.65(95%置信区间,1.22 - 10.89)]、男性性别[OR,2.99(95%置信区间,1.18 - 7.54)]、血尿素[OR,2.76(95%置信区间,1.20 - 6.35)]和低PaO2/FiO2比值[OR,0.28(95%置信区间,0.12 - 0.62)]。
COVID-19的死亡率为13.2%。与院内死亡相关的风险因素为高龄、男性性别、血尿素升高和PaO2/FiO2比值降低。